LR Health & Beauty announced its financial results for the fourth quarter 2025 and preliminary sales and earnings results for full year 2025. Revenue during the quarter was $80.3 million, a 10.9% decline that the company attributed to subdued consumer sentiment in Western European markets.

LR Health & Beauty SE has reached an agreement with significant investors to realign its financing structure. This comprehensive restructuring of its 2024/2028 Bond and capital structure is expected to provide for an aggregate injection of fresh capital of $23 million and significantly reduce and restructure the company’s debt

LR Health & Beauty SE announced its preliminary financial results for 2025. Total sales for full-year 2025 are now expected to reach $328 million, solidly in line with previously released guidance of $327 million to $333 million.

LR Health & Beauty SE reported on its business development in the third quarter of 2025. Sales during the period reached $76.8 million, with the first nine months cumulatively driving $242.9 million in sales. This cumulative amount represents a 1.8% decrease year-over-year.

LR Health & Beauty SE published its financial results for the first six months of 2025. Sales during the first half of 2025 totaled $166.6 million, a slight decrease (0.3%) from the first half of last year.

The center and adjoining skywalk and viewing platform will offer distributors a glimpse into the company’s packaging and shipping processes, while lighting installations, projects and cinema seats will create what the company hopes will be an immersive and memorable experience.

LR Health & Beauty announced their financial results for the first quarter of 2025. In the first three months of the financial year 2025, LR Health & Beauty SE generated sales (revenue from goods sold) of $79.92 million (Q1 2024: $78.4 million). The company increased sales by 2.0% compared to the first quarter of the previous year.

LR Health & Beauty reported its financial results for 2024. Sales increased to $327.9 million in 2024, representing a year-over-year boost of 4.6%. This increase was driven primarily by the realignment of the career plan and successful launches of the company’s cosmetics line and intestinal metabolism treatment.

LR Health & Beauty SE announced its financial results for the fourth quarter and full year 2024. Fourth quarter sales increased by 8% year-over-year to $80 million with an EBITDA of $8.7 million.

LR Health & Beauty honored its company legacy and history as it celebrated its 40th anniversary. The company reflected on its product and sales innovations in 2024, including its LR Health Mission and LR ZEITGARD Signature, as important foundations for future growth.

LR Health & Beauty reported a 7.2% increase in sales in Q3 2024. Total revenue in the quarter reached $73.32 million in sales. The company attributed this revenue boost primarily to the high demand for its new decorative cosmetics line LR ZEITGARD Signature and a large influx of new sales partners as a result of the realignment of its career plan.

LR Health & Beauty SE announced its financial results for the third quarter of 2024. Sales during the quarter increased by 7.2% to $73.2 million. EBITDA during the quarter increased to $7.7 million.